Bifidobacterium adolescentis CCFM1062

N/A

Report date: 2024/01/10 17:54:28

Base Information

Drug NameBifidobacterium adolescentis CCFM1062
Drug Alias Name青春双歧杆菌CCFM1062青春双歧杆菌CCFM-1062Bifidobacterium adolescentis CCFM-1062
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsObesityMetabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangnan University
China Registration ClassN/A

Develop Information

Active CompaniesJiangnan University
Inactive CompaniesN/A
Active IndicationsObesityMetabolic Dysfunction-Associated Steatotic Liver Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A